Serum interleukin-15 levels are not elevated in patients with stage I and II mycosis fungoides [7]

Acta Dermato-Venereologica

Volumn 80, Issue 6, 2000, Pages 455-

  Sugaya, M ^a   Nakamura, K ^a   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; IMMUNOREACTIVITY; LETTER; LYMPHOCYTIC INFILTRATION; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; SEZARY SYNDROME;

AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-15; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM STAGING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034488461     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Cloning of a T-cell growth factor that interacts with the beta chain of the interleukin-2 receptor
2. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells
3. Report of the Committee on Staging and Classification of Cutaneous T-cell Lympbomas
4. Interleukin-7 is a growth factor for Sezary lymphoma cells
5. IL-7 mRNA is not overexpressed in mycosis fungoides and pleomorphic T-cell lymphoma and is likely to be an autocrine growth factor in vivo
6. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications